`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`HIKMA PHARMACEUTICALS USA INC.,
`HIKMA PHARMACEUTICALS PLC,
`Petitioner,
`v.
`
`
`
`
`
`AMARIN PHARMACEUTICALS IRELAND LIMITED,
`Patent Owner.
`
`
`
`
`PTAB Case No. IPR2022-00215
`Patent No. 8,642,077 B2
`
`
`
`
`PATENT OWNER’S MANDATORY NOTICES
`
`
`
`
`
`
`
`
`
`
`
`
`
`Patent Owner’s Mandatory Notices
`PTAB Case No. IPR2022-00215
`
`Patent Owner Amarin Pharmaceuticals Ireland Limited submits the
`
`following Patent Owner Mandatory Notices.
`
`1.
`
`Real Party-In-Interest
`
`In accordance with 37 C.F.R. § 42.8(b)(1), Amarin Pharmaceuticals
`
`Ireland Limited is the real party in interest in the above IPR petition.
`
`2.
`
`Related Matters
`
`In accordance with 37 C.F.R. § 42.8(b)(2), Patent Owner Amarin
`
`Pharmaceuticals Ireland Limited
`
`identifies
`
`the following related matter
`
`(excluding this IPR proceeding) at the time of this filing: civil action styled
`
`Amarin Pharma, Inc. et al. v. Hikma Pharmaceuticals USA Inc. et al., Case No.
`
`1:20-cv-01630 (D. Del.).
`
`3.
`
`Lead and Back-Up Counsel
`
`In accordance with 37 C.F.R. § 42.8(b)(3), Amarin Pharmaceuticals
`
`Ireland Limited appoints the following lead and back-up counsel:
`
`LEAD COUNSEL
`David B. Fournier
`USPTO Reg. No. 51,696
`Perkins Coie LLP
`110 North Wacker Drive, Suite 3400
`Chicago, Illinois 60606-1511
`Phone: 312-324-8400
`Fax: 312-324-9400
`fournier-ptab@perkinscoie.com
`
`BACK-UP COUNSEL
`Kourtney Mueller Merrill
`USPTO Reg. No. 58,195
`Perkins Coie LLP
`1900 Sixteenth Street Suite 1400
`Denver, Colorado 80202-5255
`Phone: 303-291-2300
`Fax: 303-291-2400
`merrill-ptab@perkinscoie.com
`
`
`
`-1-
`
`
`
`Patent Owner’s Mandatory Notices
`PTAB Case No. IPR2022-00215
`
`
`
`In accordance with 37 C.F.R. § 42.10(b), an executed Power of Attorney
`
`with the above designation of counsel is filed herewith.
`
`
`
`
`
`4.
`
`Service Information
`
`Please address all correspondence to the lead and back-up counsel at the
`
`addresses shown above. In accordance with 37 C.F.R. § 42.8(b)(4), Patent Owner
`
`consents to electronic service.
`
`Amarin Pharmaceuticals Ireland Limited identifies the following postal
`
`mailing and hand-delivery address:
`
`Perkins Coie LLP
`110 North Wacker Drive, Suite 3400
`Chicago, Illinois 60606-1511
`Phone: 312-324-8400
`Fax: 312-324-9400
`
`Respectfully submitted,
`
`Dated: March 8, 2022
`
`
`
`
`
`
`PERKINS COIE LLP
`110 North Wacker Drive, Suite 3400
`Chicago, Illinois 60606-1511
`Phone: 312-324-8400
`
` /Kourtney Mueller Merrill/
`Lead Counsel
`David B. Fournier, Reg. No. 51,696
`
`Back-Up Counsel
`Kourtney Mueller Merrill, Reg. No. 58,195
`
`for Amarin Pharmaceuticals
`Attorneys
`Ireland Limited
`
`
`
`-2-
`
`
`
`Patent Owner’s Mandatory Notices
`PTAB Case No. IPR2022-00215
`CERTIFICATE OF SERVICE
`
`I hereby certify that on this 8th day of March, 2022, true and correct copies
`
`of the foregoing PATENT OWNER'S MANDATORY NOTICES and POWER OF
`
`ATTORNEY were served via electronic mail on Petitioner’s counsel at the
`
`following address:
`
`Jovial Wong, Charles B. Klein, Eimeric Reig-Plessis,
`Claire A. Fundakowski, Alison M. King
`HikmaIPR@winston.com
`
`
`Dated: March 8, 2022
`
`
`PERKINS COIE LLP
`1201 Third Avenue Suite 4900
`Seattle, WA 98101-3099
`
`
`Respectfully submitted,
`
` /Meghan Bright/
`Meghan Bright
`Patent Paralegal
`
`
`
`
`
`-3-
`
`